These compounds may interact with:

Sphingosine 1-phosphate receptor 2

Potentially involved in: nonsyndromic deafness; autosomal recessive nonsyndromic deafness 68; vascular disease; diabetes mellitus, experimental; sensorineural hearing loss (disorder); heart diseases; neoplasm invasiveness; deafness, autosomal recessive 68; infantile onset; autosomal recessive predisposition

Disease data sourced from Pharos.